The Bombay High Court today allowed baby products manufacturer Johnson & Johnson to restart the manufacturing of baby powder at its Mulund unit, which had been stopped upon the order of Maharashtra Food and Drug Administration.
The Honourable High Court passed this judgment after due consideration of all facts related to the case. The court also found the company's offer to test the batches of baby powder in question, reasonable. Further, there was no scientific foundation that there were any carcinogens present in that batch of baby powder.
"Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families," said a Johnson & Johnson, India spokesperson.
For the past 100 years, Johnson & Johnson has earned the trust of over one billion families and healthcare professionals. Johnson's® Baby aspires to touch every baby in India with brands operating in the widest consumer spectrum.